A large British study looking into potential early-stage Covid-19 treatments will begin testing gout medication colchicine and has widened enrolment criteria for the arm of the trial, University of Oxford researchers said on Wednesday.
Gout drug to be tested as potential Covid-19 treatment by second UK study (Photo by Daniel Schludi on Unsplash)
The anti-inflammatory drug is already being tested in another UK study dubbed RECOVERY, which is the world's largest clinical trial of treatments for patients hospitalised with Covid-19.